期刊文献+

Current status of intragastric balloon for obesity treatment 被引量:2

Current status of intragastric balloon for obesity treatment
下载PDF
导出
摘要 Endoscopic bariatric therapy may be a useful alternative to pharmacological treatment for obesity, and it provides greater efficacy with lower risks than do conventional surgical procedures. Among the various endoscopic treatments for obesity, the intragastric balloon is associated with significant efficacy in body weight reduction and relief of comorbid disease symptoms. Anatomically, this treatment is based on gastric space-occupying effects that increase the feeling of satiety and may also affect gut neuroendocrine signaling. The simplicity of the intragastric balloon procedure may account for its widespread role in obesity treatment and its applicability to various degrees of obesity. However, advances in device properties and procedural techniques are still needed in order to improve its safety and cost-effectiveness. Furthermore, verification of the physiological outcomes of intragastric balloon treatment and the clinical predictive factors for treatment responses should be considered. In this article, we discuss the types, efficacy, safety, and future directions of intragastric balloon treatment. Endoscopic bariatric therapy may be a useful alternative to pharmacological treatment for obesity, and it provides greater efficacy with lower risks than do conventional surgical procedures. Among the various endoscopic treatments for obesity, the intragastric balloon is associated with significant efficacy in body weight reduction and relief of comorbid disease symptoms. Anatomically, this treatment is based on gastric space-occupying effects that increase the feeling of satiety and may also affect gut neuroendocrine signaling. The simplicity of the intragastric balloon procedure may account for its widespread role in obesity treatment and its applicability to various degrees of obesity. However, advances in device properties and procedural techniques are still needed in order to improve its safety and cost-effectiveness. Furthermore, verification of the physiological outcomes of intragastric balloon treatment and the clinical predictive factors for treatment responses should be considered. In this article, we discuss the types, efficacy, safety, and future directions of intragastric balloon treatment.
出处 《World Journal of Gastroenterology》 SCIE CAS 2016年第24期5495-5504,共10页 世界胃肠病学杂志(英文版)
基金 Supported by Korea Health Technology R and D Project through the Korea Health Industry Development Institute,and Ministry of Health and Welfare,South Korea,No.HI14C3477
关键词 Intragastric BALLOON OBESITY BARIATRIC METABOLIC ENDOSCOPY Intragastric balloon Obesity Bariatric Metabolic Endoscopy
  • 相关文献

参考文献86

  • 1Theodossis Papavramidis,Vasilis Grosomanidis,Pyrros Papakostas,Sofia Penna,Katerina Kotzampassi.??Intragastric Balloon Fundal or Antral Position Affects Weight Loss and Tolerability(J)Obesity Surgery . 2012 (6)
  • 2Maria Grazia Farina,Roberto Baratta,Angela Nigro,Federica Vinciguerra,Concetta Puglisi,Roberto Schembri,Clara Virgilio,Riccardo Vigneri,Lucia Frittitta.??Intragastric Balloon in Association with Lifestyle and/or Pharmacotherapy in the Long-Term Management of Obesity(J)Obesity Surgery . 2012 (4)
  • 3Gregory G. Ginsberg,Bipan Chand,Gregory A. Cote,Ramsey M. Dallal,Steven A. Edmundowicz,Ninh T. Nguyen,Aurora Pryor,Christopher C. Thompson.??A pathway to endoscopic bariatric therapies(J)Gastrointestinal Endoscopy . 2011 (5)
  • 4Selective Reduction in Neural Responses to High Calorie Foods Following Gastric Bypass Surgery(J)Annals of Surgery . 2011 (3)
  • 5Maria Luisa Castro,María José Morales,Víctor Campo,Juan R. Pineda,Eduardo Pena,José M. Sierra,María José Arbones,Ignacio R. Prada.??Efficacy, Safety, and Tolerance of Two Types of Intragastric Balloons Placed in Obese Subjects: A Double-Blind Comparative Study(J)Obesity Surgery . 2010 (12)
  • 6Ana B. Crujeiras,Estíbaliz Goyenechea,Itziar Abete,Mary Lage,Marcos C. Carreira,J. Alfredo Martínez,Felipe F. Casanueva.??Weight Regain after a Diet-Induced Loss Is Predicted by Higher Baseline Leptin and Lower Ghrelin Plasma Levels(J)The Journal of Clinical Endocrinology & Metabolism . 2010 (11)
  • 7Christopher N. Ochner,Charlisa Gibson,Susan Carnell,Carl Dambkowski,Allan Geliebter.??The neurohormonal regulation of energy intake in relation to bariatric surgery for obesity(J)Physiology & Behavior . 2010 (5)
  • 8Rosario Forlano,Antonio Massimo Ippolito,Angelo Iacobellis,Antonio Merla,Maria Rosa Valvano,Grazia Niro,Vito Annese,Angelo Andriulli.??Effect of the BioEnterics intragastric balloon on weight, insulin resistance, and liver steatosis in obese patients(J)Gastrointestinal Endoscopy . 2010 (6)
  • 9N.Delzenne,J.Blundell,F.Brouns,K.Cunningham,K.De Graaf,A.Erkner,A.Lluch,M.Mars,H. P. F.Peters,M.Westerterp‐Plantenga.??Gastrointestinal targets of appetite regulation in humans(J)Obesity Reviews . 2010 (3)
  • 10Nicola Crea,Giacomo Pata,Domenico Della Casa,Luigi Minelli,Giovanni Maifredi,Ernesto Betta,Francesco Mittempergher.??Improvement of Metabolic Syndrome Following Intragastric Balloon: 1 Year Follow-up Analysis(J)Obesity Surgery . 2009 (8)

二级参考文献16

  • 1[1]Claik JM,Diehl AM.Defining nonalcoholic fatty liver disease:implications for epidemiologic studies.Gastroenterology 2003; 124:248-250
  • 2[2]Whitfteld JB,Zhu G,Nestler JE,Heath AC Martin NG.Genetic covariation between serum gamma-glutamyltransferase activity and cardiovascular risk factors.Clin Chem 2002; 48:1426-1431
  • 3[3]Nakanishi N,Suzuki K,Tatara K.Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men.Diabetes Care 2004; 27:1427-1432
  • 4[4]Angulo P.Nonalcoholic fatty liver disease.N EnglJMed 2002; 346:1221-1231
  • 5[5]Executive Summary of The Third Report of The NationalCholesterol Education Program (NCEP) Expert Panel on Detection,Evaluation,And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).JAMA 2001; 285:2486-2497
  • 6[6]Clark JM.The epidemiology of nonalcoholic fatty liver disease in adults.J Out Gastroenterol 2006; 40:S5-S10
  • 7[7]Ruhl CE,Everhart JE.Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States.Gastroenterology 2003; 124:71-79
  • 8[8]Gasbarrini G,Vero V,Miele L,Forgione A,Hernandez AP,Greco AV,Gasbarrini A,Grieco A.Nonalcoholic fatty liver disease:defining a common problem.Eur Rev Med Pharmacol Sci 2005; 9:253-259
  • 9[9]Azizi F,Salehi P,Etemadi A,Zahedi-Asl S.Prevalence of metabolic syndrome in an urban population:Tehran Iipid and Glucose Study.Diabetes Res din Pract 2003; 61:29-37
  • 10[10]Kim HC,Choi SH,Shin HW,Cheong JY,Lee KW,Lee HC,Huh KB,Kim DJ.Severity of ultrasonographic liver steatosis and metabolic syndrome in Korean men and women.World J Gastroenterol 2005; 11:5314-5321

共引文献14

同被引文献1

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部